Healthcare Sector
Market Tracker
15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.
Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.
Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.
Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.
| Name | Pct Held | Shares | Total |
|---|---|---|---|
| Fidelity NASDAQ Composite Index ETF | 0.06% | 22.47k | 202.71k |
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CARM, ENZB, HSON, TTNP on Behalf of Shareholders
07/26 01:47 pm
GlobeNewswire Inc.
Read moreSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates NVEE, CARM, HLGN on Behalf of Shareholders
07/16 11:32 am
Benzinga
Read more$HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger: TURN, HLGN, CARM, and GNTY
07/14 08:31 pm
Benzinga
Read moreSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BASE, CARM, ENZB on Behalf of Shareholders
07/05 09:48 am
GlobeNewswire Inc.
Read moreSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates GMS, BASE, CARM, ENZB on Behalf of Shareholders
07/01 06:18 pm
Benzinga
Read moreOcugen (OCGN) Shares Slide Following Merger Agreement: What's Going On?
06/23 02:26 pm
Benzinga
Read moreIn-Depth Examination Of 5 Analyst Recommendations For CARISMA Therapeutics
06/26 02:01 pm
Benzinga
Read moreThe Analyst Verdict: CARISMA Therapeutics In The Eyes Of 4 Experts
05/17 11:01 am
Benzinga
Read moreCarisma Therapeutics Inc. (CARM) Reports Q1 Loss, Misses Revenue Estimates
05/09 08:35 am
Zacks Investment Research
Read moreCarisma Therapeutics Inc. (CARM) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
05/02 10:01 am
Zacks Investment Research
Read moreHere's Why CARISMA THERAP (CARM) Is a Great 'Buy the Bottom' Stock Now
04/04 09:55 am
Zacks Investment Research
Read moreWall Street Breakfast: The Week Ahead
03/31 07:38 am
Seeking Alpha
Read moreBenzinga's Top Ratings Upgrades, Downgrades For October 3, 2023
10/03 11:00 am
Benzinga
Read moreWhat 5 Analyst Ratings Have To Say About CARISMA Therapeutics
09/06 10:00 am
Benzinga
Read moreWall Street Analysts Predict a 48.37% Upside in Carisma Therapeutics Inc. (CARM): Here's What You Should Know
08/23 09:55 am
Zacks Investment Research
Read moreAnalyst Ratings for CARISMA Therapeutics
08/11 08:00 am
Benzinga
Read moreWhy Siyata Mobile Shares Are Trading Lower By 21%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
07/11 01:26 pm
Benzinga
Read moreBenzinga's Top Ratings Upgrades, Downgrades For July 6, 2023
07/06 11:02 am
Benzinga
Read moreSteelcase, Commercial Metals And Other Big Stocks Moving Higher On Thursday
06/22 10:58 am
Benzinga
Read moreWhy Couchbase Shares Are Trading Lower By Around 19%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
06/07 02:02 pm
Benzinga
Read moreBenzinga's Top Ratings Upgrades, Downgrades For May 24, 2023
05/24 11:00 am
Benzinga
Read moreBenzinga's Top Ratings Upgrades, Downgrades For April 14, 2023
04/14 11:00 am
Benzinga
Read more